Diabetic polyneuropathies

Update on research definition, diagnostic criteria and estimation of severity

Peter J. Dyck, James W. Albers, Henning Andersen, Joseph C. Arezzo, Geert Jan Biessels, Vera Bril, Eva L. Feldman, William J. Litchy, Peter C. O'Brien, James W. Russell

Research output: Contribution to journalArticle

157 Citations (Scopus)

Abstract

Prior to a joint meeting of the Neurodiab Association and International Symposium on Diabetic Neuropathy held in Toronto, Ofntario, Canada, 13-18 October 2009, Solomon Tesfaye, Sheffield, UK, convened a panel of neuromuscular experts to provide an update on polyneuropathies associated with diabetes (Toronto Consensus Panels on DPNs, 2009). Herein, we provide definitions of typical and atypical diabetic polyneuropathies (DPNs), diagnostic criteria, and approaches to diagnose sensorimotor polyneuropathy as well as to estimate severity. Diabetic sensorimotor polyneuropathy (DSPN), or typical DPN, usually develops on long-standing hyperglycaemia, consequent metabolic derangements and microvessel alterations. It is frequently associated with microvessel retinal and kidney disease-but other causes must be excluded. By contrast, atypical DPNs are intercurrent painful and autonomic small-fibre polyneuropathies. Recognizing that there is a need to detect and estimate severity of DSPN validly and reproducibly, we define subclinical DSPN using nerve conduction criteria and define possible, probable, and confirmed clinical levels of DSPN. For conduct of epidemiologic surveys and randomized controlled trials, it is necessary to pre-specify which attributes of nerve conduction are to be used, the criterion for diagnosis, reference values, correction for applicable variables, and the specific criterion for DSPN. Herein, we provide the performance characteristics of several criteria for the diagnosis of sensorimotor polyneuropathy in healthy subject- and diabetic subject cohorts. Also outlined here are staged and continuous approaches to estimate severity of DSPN.

Original languageEnglish (US)
Pages (from-to)620-628
Number of pages9
JournalDiabetes/Metabolism Research and Reviews
Volume27
Issue number7
DOIs
StatePublished - Oct 2011

Fingerprint

Diabetic Neuropathies
Research
Polyneuropathies
Neural Conduction
Microvessels
Retinal Diseases
Kidney Diseases
Hyperglycemia
Canada
Healthy Volunteers
Reference Values
Randomized Controlled Trials

Keywords

  • Atypical diabetic polyneuropathy
  • Classification
  • Definitions
  • Diabetic polyneuropathy
  • Diabetic sensorimotor polyneuropathy

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Medicine(all)

Cite this

Diabetic polyneuropathies : Update on research definition, diagnostic criteria and estimation of severity. / Dyck, Peter J.; Albers, James W.; Andersen, Henning; Arezzo, Joseph C.; Biessels, Geert Jan; Bril, Vera; Feldman, Eva L.; Litchy, William J.; O'Brien, Peter C.; Russell, James W.

In: Diabetes/Metabolism Research and Reviews, Vol. 27, No. 7, 10.2011, p. 620-628.

Research output: Contribution to journalArticle

Dyck, PJ, Albers, JW, Andersen, H, Arezzo, JC, Biessels, GJ, Bril, V, Feldman, EL, Litchy, WJ, O'Brien, PC & Russell, JW 2011, 'Diabetic polyneuropathies: Update on research definition, diagnostic criteria and estimation of severity', Diabetes/Metabolism Research and Reviews, vol. 27, no. 7, pp. 620-628. https://doi.org/10.1002/dmrr.1226
Dyck, Peter J. ; Albers, James W. ; Andersen, Henning ; Arezzo, Joseph C. ; Biessels, Geert Jan ; Bril, Vera ; Feldman, Eva L. ; Litchy, William J. ; O'Brien, Peter C. ; Russell, James W. / Diabetic polyneuropathies : Update on research definition, diagnostic criteria and estimation of severity. In: Diabetes/Metabolism Research and Reviews. 2011 ; Vol. 27, No. 7. pp. 620-628.
@article{aad32a9bc4214937b62caf2d44b3f432,
title = "Diabetic polyneuropathies: Update on research definition, diagnostic criteria and estimation of severity",
abstract = "Prior to a joint meeting of the Neurodiab Association and International Symposium on Diabetic Neuropathy held in Toronto, Ofntario, Canada, 13-18 October 2009, Solomon Tesfaye, Sheffield, UK, convened a panel of neuromuscular experts to provide an update on polyneuropathies associated with diabetes (Toronto Consensus Panels on DPNs, 2009). Herein, we provide definitions of typical and atypical diabetic polyneuropathies (DPNs), diagnostic criteria, and approaches to diagnose sensorimotor polyneuropathy as well as to estimate severity. Diabetic sensorimotor polyneuropathy (DSPN), or typical DPN, usually develops on long-standing hyperglycaemia, consequent metabolic derangements and microvessel alterations. It is frequently associated with microvessel retinal and kidney disease-but other causes must be excluded. By contrast, atypical DPNs are intercurrent painful and autonomic small-fibre polyneuropathies. Recognizing that there is a need to detect and estimate severity of DSPN validly and reproducibly, we define subclinical DSPN using nerve conduction criteria and define possible, probable, and confirmed clinical levels of DSPN. For conduct of epidemiologic surveys and randomized controlled trials, it is necessary to pre-specify which attributes of nerve conduction are to be used, the criterion for diagnosis, reference values, correction for applicable variables, and the specific criterion for DSPN. Herein, we provide the performance characteristics of several criteria for the diagnosis of sensorimotor polyneuropathy in healthy subject- and diabetic subject cohorts. Also outlined here are staged and continuous approaches to estimate severity of DSPN.",
keywords = "Atypical diabetic polyneuropathy, Classification, Definitions, Diabetic polyneuropathy, Diabetic sensorimotor polyneuropathy",
author = "Dyck, {Peter J.} and Albers, {James W.} and Henning Andersen and Arezzo, {Joseph C.} and Biessels, {Geert Jan} and Vera Bril and Feldman, {Eva L.} and Litchy, {William J.} and O'Brien, {Peter C.} and Russell, {James W.}",
year = "2011",
month = "10",
doi = "10.1002/dmrr.1226",
language = "English (US)",
volume = "27",
pages = "620--628",
journal = "Diabetes/Metabolism Research and Reviews",
issn = "1520-7552",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Diabetic polyneuropathies

T2 - Update on research definition, diagnostic criteria and estimation of severity

AU - Dyck, Peter J.

AU - Albers, James W.

AU - Andersen, Henning

AU - Arezzo, Joseph C.

AU - Biessels, Geert Jan

AU - Bril, Vera

AU - Feldman, Eva L.

AU - Litchy, William J.

AU - O'Brien, Peter C.

AU - Russell, James W.

PY - 2011/10

Y1 - 2011/10

N2 - Prior to a joint meeting of the Neurodiab Association and International Symposium on Diabetic Neuropathy held in Toronto, Ofntario, Canada, 13-18 October 2009, Solomon Tesfaye, Sheffield, UK, convened a panel of neuromuscular experts to provide an update on polyneuropathies associated with diabetes (Toronto Consensus Panels on DPNs, 2009). Herein, we provide definitions of typical and atypical diabetic polyneuropathies (DPNs), diagnostic criteria, and approaches to diagnose sensorimotor polyneuropathy as well as to estimate severity. Diabetic sensorimotor polyneuropathy (DSPN), or typical DPN, usually develops on long-standing hyperglycaemia, consequent metabolic derangements and microvessel alterations. It is frequently associated with microvessel retinal and kidney disease-but other causes must be excluded. By contrast, atypical DPNs are intercurrent painful and autonomic small-fibre polyneuropathies. Recognizing that there is a need to detect and estimate severity of DSPN validly and reproducibly, we define subclinical DSPN using nerve conduction criteria and define possible, probable, and confirmed clinical levels of DSPN. For conduct of epidemiologic surveys and randomized controlled trials, it is necessary to pre-specify which attributes of nerve conduction are to be used, the criterion for diagnosis, reference values, correction for applicable variables, and the specific criterion for DSPN. Herein, we provide the performance characteristics of several criteria for the diagnosis of sensorimotor polyneuropathy in healthy subject- and diabetic subject cohorts. Also outlined here are staged and continuous approaches to estimate severity of DSPN.

AB - Prior to a joint meeting of the Neurodiab Association and International Symposium on Diabetic Neuropathy held in Toronto, Ofntario, Canada, 13-18 October 2009, Solomon Tesfaye, Sheffield, UK, convened a panel of neuromuscular experts to provide an update on polyneuropathies associated with diabetes (Toronto Consensus Panels on DPNs, 2009). Herein, we provide definitions of typical and atypical diabetic polyneuropathies (DPNs), diagnostic criteria, and approaches to diagnose sensorimotor polyneuropathy as well as to estimate severity. Diabetic sensorimotor polyneuropathy (DSPN), or typical DPN, usually develops on long-standing hyperglycaemia, consequent metabolic derangements and microvessel alterations. It is frequently associated with microvessel retinal and kidney disease-but other causes must be excluded. By contrast, atypical DPNs are intercurrent painful and autonomic small-fibre polyneuropathies. Recognizing that there is a need to detect and estimate severity of DSPN validly and reproducibly, we define subclinical DSPN using nerve conduction criteria and define possible, probable, and confirmed clinical levels of DSPN. For conduct of epidemiologic surveys and randomized controlled trials, it is necessary to pre-specify which attributes of nerve conduction are to be used, the criterion for diagnosis, reference values, correction for applicable variables, and the specific criterion for DSPN. Herein, we provide the performance characteristics of several criteria for the diagnosis of sensorimotor polyneuropathy in healthy subject- and diabetic subject cohorts. Also outlined here are staged and continuous approaches to estimate severity of DSPN.

KW - Atypical diabetic polyneuropathy

KW - Classification

KW - Definitions

KW - Diabetic polyneuropathy

KW - Diabetic sensorimotor polyneuropathy

UR - http://www.scopus.com/inward/record.url?scp=80053580486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053580486&partnerID=8YFLogxK

U2 - 10.1002/dmrr.1226

DO - 10.1002/dmrr.1226

M3 - Article

VL - 27

SP - 620

EP - 628

JO - Diabetes/Metabolism Research and Reviews

JF - Diabetes/Metabolism Research and Reviews

SN - 1520-7552

IS - 7

ER -